BioFluidica Announces $6 Million Series B2 Funding to Support the Commercialization of its Liquid Biopsy Microfluidics Platform, the LiquidScan™, and the Development of its Advanced Handheld Covid-19 Detection Device for Consumer At-Home Te ...Middle East

Hence then, the article about biofluidica announces 6 million series b2 funding to support the commercialization of its liquid biopsy microfluidics platform the liquidscan and the development of its advanced handheld covid 19 detection device for consumer at home te was published today ( Wednesday 09/02/2022 - 03:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioFluidica Announces $6 Million Series B2 Funding to Support the Commercialization of its Liquid Biopsy Microfluidics Platform, the LiquidScan™, and the Development of its Advanced Handheld Covid-19 Detection Device for Consumer At-Home Te )

Also on site :

• French court denies extradition of ex-Tunisian President Ben Ali’s daughter
• Ford and Toyota issue major South African car recall
• ‘It all depends on the crop’: Gulf crisis hits South Asia farmers